Skip to main content
. Author manuscript; available in PMC: 2014 Jul 18.
Published in final edited form as: Urol Res. 2010 Dec 17;39(4):303–307. doi: 10.1007/s00240-010-0347-5

Table 1.

Demographics of prevalence study

Variable Median (interquartile range)
p value
Patients with symptomatic stone (n = 8) Patients without symptomatic stones (n = 67)
Age (years) 40 (34–62) 40 (32–50) 0.45
Gender 0.45
Female (%) 53 66
Male (%) 47 34
Height (cm) 175 (166–183) 167 (160–172) 0.16
Weight (kg) 85 (76–95) 78 (64–95) 0.45
BMI (kg/m2) 28 (24–38) 28 (24–33) 0.93
TPM dose (mg/day) 400 (188–425) 300 (200–400) 0.63
TPM duration (months) 48 (41–59) 24 (18–60) 0.44